The two new distributors companies include Ahsan Anaesthetist who will be responsible for sales in Ireland, and the Mediterranean for Technology & Trading SAL Offshore (MTT- Elyssa Holding) who will be responsible for sales in sixteen countries in the Middle East and North Africa.

CTTC’s non-invasive Calmare pain therapy medical device incorporates the biophysical Scrambler Therapy technology to treat neuropathic pain, including cancer pain.

CTTC International Business Development MD Umberto Marangoni said they believe these agreements and a number of others they are currently negotiating in additional countries are a reflection of the increased worldwide interest in their non-invasive pain therapy which is free of harmful side effects.